FDA calls for cocaine, meth addiction meds

The Food and Drug Administration issued draft guidance to facilitate the development of clinical trials for drugs aimed at treating moderate to severe cocaine use disorder, methamphetamine use disorder or prescription stimulant use disorder. The remit does not cover polydrug use. Ho hum: more bandaids.